Literature DB >> 11544299

Regulation of IgE production requires oligomerization of CD23.

M A Kilmon1, R Ghirlando, M P Strub, R L Beavil, H J Gould, D H Conrad.   

Abstract

Here we describe the production of a rabbit polyclonal Ab (RAS1) raised against the stalk of murine CD23. RAS1 inhibits release of CD23 from the surface of both M12 and B cells resulting in an increase of CD23 on the cell surface. Despite this increase, these cells are unable to bind IgE as determined by FACS. CD23 has previously been shown to bind IgE with both a high (4-10 x 10(7) M(-1)) and low (4-10 x 10(6) M(-1)) affinity. Closer examination by direct binding of (125)I-IgE revealed that RAS1 blocks high affinity binding while having no effect on low affinity binding. These data support the model proposing that oligomers of CD23 mediate high affinity IgE binding. These experiments suggest that RAS1 binding to cell surface CD23 results in a shift from oligomers to monomers, which, according to the model, only bind IgE with low affinity. These experiments also suggest that high affinity binding of IgE is required for IgE regulation by CD23 and is demonstrated by the fact that treatment of Ag/Alum-immunized mice treated with RAS1 results in a significant increase in IgE production similar to the levels seen in CD23-deficient mice. These mice also had significantly decreased levels of serum soluble CD23 and Ag-specific IgG1. RAS1 had no effect on IgE or Ag-specific IgG1 production in CD23-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544299     DOI: 10.4049/jimmunol.167.6.3139

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.

Authors:  Joel A Mathews; David R Gibb; Bing-Hung Chen; Peggy Scherle; Daniel H Conrad
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

2.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

Review 3.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

4.  CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells.

Authors:  Daniel Onguru; YanMei Liang; Jennifer Elliot; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 5.  Soluble IgE receptors--elements of the IgE network.

Authors:  Barbara Platzer; Floortje Ruiter; John van der Mee; Edda Fiebiger
Journal:  Immunol Lett       Date:  2011-09-06       Impact factor: 3.685

6.  How to connect an IgE-driven response with CTL activity?

Authors:  Barbara Platzer; Eleonora Dehlink; Shannon J Turley; Edda Fiebiger
Journal:  Cancer Immunol Immunother       Date:  2011-11-01       Impact factor: 6.968

7.  Necessity of the stalk region for immunoglobulin E interaction with CD23.

Authors:  Bing-Hung Chen; Check Ma; Timothy H Caven; Yee Chan-Li; Andrew Beavil; Rebecca Beavil; Hannah Gould; Daniel H Conrad
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

8.  A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma.

Authors:  J A Mathews; J Ford; S Norton; D Kang; A Dellinger; D R Gibb; A Q Ford; H Massay; C L Kepley; P Scherle; A D Keegan; D H Conrad
Journal:  Allergy       Date:  2011-05-10       Impact factor: 13.146

9.  Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.

Authors:  Eri Yasuoka; Kazuo Oshima; Katsuto Tamai; Takeshi Kubo; Yasufumi Kaneda
Journal:  J Mol Med (Berl)       Date:  2006-10-28       Impact factor: 4.599

10.  129/SvJ mice have mutated CD23 and hyper IgE.

Authors:  Jill W Ford; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2008-10-01       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.